Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timucin Taner

Showing results (31-40 of 127) with videos related to

Pageof 13
Sort By:
Transplantation|May 20, 2022
New Approaches to the Diagnosis of Rejection and Prediction of Tolerance in Liver TransplantationTimucin Taner, Julia Bruner, Juliet Emamaullee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2003
Cutting edge: sanglifehrin A, a novel cyclophilin-binding immunosuppressant blocks bioactive IL-12 production by human dendritic cellsChristoph Steinschulte, Timucin Taner, Angus W Thomson, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|October 21, 2020
Characteristics and Outcomes of Kidney Transplant Recipients Requiring High-Acuity Care After Transplant Surgery: A 10-Year Single-Center StudyNitin Abrol, Rahul Kashyap, Kianoush B Kashani, et al.
Journal of Hepatology|May 19, 2023
Issues in multi-organ transplantation of the liver with kidney or heart in polycystic liver-kidney disease or congenital heart disease: Current practices and immunological aspectsTimucin Taner, Moira B Hilscher, Christopher R Broda, et al.
Transplantation Direct|February 26, 2020
Influence of Intraoperative Transesophageal Echocardiography and Pulmonary Artery Catheter Monitoring on Outcomes in Liver TransplantationRyan E Hofer, Matthew N P Vogt, Timucin Taner, et al.
Transplantation|September 24, 2013
Down-regulating humoral immune responses: implications for organ transplantationMark D Stegall, Natalie Moore, Timucin Taner, et al.
Clinical Transplantation|February 20, 2024
De novo hepatitis B infection following liver transplantation with core antibody positive grafts: The role of surface antibody status in guiding long-term prophylaxisBrad Busebee, Laura Myhre, Kristin Mara, et al.
Transplantation|June 24, 2003
Pharmacologic, biologic, and genetic engineering approaches to potentiation of donor-derived dendritic cell tolerogenicityP Toby H Coates, Bridget L Colvin, Katsuhiko Kaneko, et al.
Journal of Cardiothoracic and Vascular Anesthesia|May 12, 2019
Use of Angiotensin II for Vasoplegic Shock in a Combined Heart and Liver Transplant Recipient with Systolic Anterior Motion PhysiologyPatrick M Wieruszewski, Charles R Sims, Richard C Daly, et al.
Cancers|October 30, 2020
Selected Patients with Unresectable Perihilar Cholangiocarcinoma (pCCA) Derive Long-Term Benefit from Liver TransplantationAdiba I Azad, Charles B Rosen, Timucin Taner, et al.
Pageof 13

Showing results (31-40 of 127) with videos related to

Sort By:
Pageof 13
Transplantation|May 20, 2022
New Approaches to the Diagnosis of Rejection and Prediction of Tolerance in Liver TransplantationTimucin Taner, Julia Bruner, Juliet Emamaullee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2003
Cutting edge: sanglifehrin A, a novel cyclophilin-binding immunosuppressant blocks bioactive IL-12 production by human dendritic cellsChristoph Steinschulte, Timucin Taner, Angus W Thomson, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|October 21, 2020
Characteristics and Outcomes of Kidney Transplant Recipients Requiring High-Acuity Care After Transplant Surgery: A 10-Year Single-Center StudyNitin Abrol, Rahul Kashyap, Kianoush B Kashani, et al.
Journal of Hepatology|May 19, 2023
Issues in multi-organ transplantation of the liver with kidney or heart in polycystic liver-kidney disease or congenital heart disease: Current practices and immunological aspectsTimucin Taner, Moira B Hilscher, Christopher R Broda, et al.
Transplantation Direct|February 26, 2020
Influence of Intraoperative Transesophageal Echocardiography and Pulmonary Artery Catheter Monitoring on Outcomes in Liver TransplantationRyan E Hofer, Matthew N P Vogt, Timucin Taner, et al.
Transplantation|September 24, 2013
Down-regulating humoral immune responses: implications for organ transplantationMark D Stegall, Natalie Moore, Timucin Taner, et al.
Clinical Transplantation|February 20, 2024
De novo hepatitis B infection following liver transplantation with core antibody positive grafts: The role of surface antibody status in guiding long-term prophylaxisBrad Busebee, Laura Myhre, Kristin Mara, et al.
Transplantation|June 24, 2003
Pharmacologic, biologic, and genetic engineering approaches to potentiation of donor-derived dendritic cell tolerogenicityP Toby H Coates, Bridget L Colvin, Katsuhiko Kaneko, et al.
Journal of Cardiothoracic and Vascular Anesthesia|May 12, 2019
Use of Angiotensin II for Vasoplegic Shock in a Combined Heart and Liver Transplant Recipient with Systolic Anterior Motion PhysiologyPatrick M Wieruszewski, Charles R Sims, Richard C Daly, et al.
Cancers|October 30, 2020
Selected Patients with Unresectable Perihilar Cholangiocarcinoma (pCCA) Derive Long-Term Benefit from Liver TransplantationAdiba I Azad, Charles B Rosen, Timucin Taner, et al.
Pageof 13